Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 trial evaluating HepaSphere interventional therapy using Digital Subtraction Angiography for lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• HepaSphere

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED